MARKET

THMO

THMO

ThermoGenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.950
0.000
0.00%
Opening 10:25 01/23 EST
OPEN
4.950
PREV CLOSE
4.950
HIGH
4.950
LOW
4.950
VOLUME
246
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
2.350
MARKET CAP
14.08M
P/E (TTM)
-1.0189
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of THMO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

THMO News

  • ThermoGenesis' JV receives $3M equity investment; shares up 13% premarket
  • Seeking Alpha - Article.01/03 13:53
  • ThermoGenesis/ImmuneCyte Joint Venture Receives $3 Million Equity Investment
  • Benzinga.01/03 13:38
  • ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment
  • PR Newswire.01/03 13:30
  • ThermoGenesis announces management changes
  • Seeking Alpha - Article.01/02 13:41

More

Industry

Office Equipment
+0.03%
Technology Equipment
-0.10%

Hot Stocks

Name
Price
%Change

About THMO

ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy market.
More

Webull offers Thermogenesis Holdings Inc (THMO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.